Nearly 30% of the estimated 476,000 people in the US each year who are diagnosed and treated for Lyme Disease are ages 0-19. Lyme disease has been called “The Great Imitator” because it often presents in children with flu-like symptoms including fever, chills, malaise and headache. It can also present with symptoms similar to COVID. Lyme Disease is frequently misdiagnosed or not diagnosed at all. If left untreated, the bacteria that cause Lyme Disease can attack many systems of a child’s body, including the skin, heart, nerves, and joints.
This activity is intended to provide healthcare professionals with the following Lyme Disease information:
2) disease presentation;
3) testing and diagnosis;
4) disease progression and management;
5) case presentations including atypical presentations;
6) medical summary and public awareness.
Pediatricians, representatives of physician office laboratories, urgent care centers and any other allied health professionals or health care researchers interested in hearing the latest information regarding the prevalence of Lyme disease in children.
1. Describe the prevalence and impact of Lyme Disease in the pediatric population.
2. Explain the clinical importance of early testing, identification, diagnosis and treatment of Lyme Disease.
3. Discuss the need for greater Lyme Disease awareness in the medical community as well as the general patient population.
Instruction Level: Basic
Robert A. Dracker, M.D.
Summerwood Pediatrics and Infusacare Medical Services
Liverpool, New York
The opinions expressed in the educational activity are those of the speaker and do not necessarily represent the views of any organization associated with this activity.
Robert A. Dracker, M.D.
- Quidel Corporation (Consultant/Independent Contractor, Honoraria)
Quidel is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
Policy on Privacy and Confidentiality
Quidel Corporation protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Quidel Corporation and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
Quidel Corporation and its educational partners maintain physical, electronic and procedural safeguards that comply with recognized accreditation regulations to guard your non-public personal information.
This program has been made available online.
Commercial Support Statement
This activity is provided by the Quidel Corporation.
IMPORTANT NOTE: Internet Explorer is no longer officially supported by the manufacturer, and functionality and vulnerability issues have been reported. Please avoid the use of Internet Explorer.
Copyright © 2021. Quidel Corporation.